Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians

ConditionLiver Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNovo Nordisk A/S

About this trial

This study is a cross-sectional survey-based study. The main goal of this study is to investigate the attitudes, perceptions, and clinical practice in assessing liver fibrosis following a metabolic dysfunction-associated steatotic liver disease (MASLD) diagnosis, and the management of MASLD patients among Chinese physicians in the departments of endocrinology / hepatology / infection / gastroenterology in Grade IIIA hospitals in provincial capitals or municipalities.

Eligibility criteria

Qualifiers

Has provided informed consent.

Registered clinical practice location in provincial capital or municipality.

Physician with a license for clinical practice.

Employed in the Department of Endocrinology, Hepatology, Infection or Gastroenterology.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • No treatment is given

Treatment groups

470 Participants
are divided into 1 treatment group

Sponsors and collaborators